# Buspirone Treatment of Iatrogenic Dyskinesias in Advanced Parkinson' Disease

> **NCT02617017** · PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 99 (actual)

## Conditions studied

- Parkinson

## Interventions

- **DRUG:** Buspirone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02617017
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-17
- **Primary completion:** 2023-03-23
- **Final completion:** 2023-03-23
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2023-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02617017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02617017, "Buspirone Treatment of Iatrogenic Dyskinesias in Advanced Parkinson' Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02617017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*